ORAI3 and benign prostatic hyperplasia: The lack of using specific inhibitors together with the ability of Orai1 and Orai3 to generate heteromeric channels in prostatic tissue [24] precludes identification of the specific STIM/Orai element responsible for functional alterations in BPH prostate, which may be considered a limitation of this study.